{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03235752: Phase 2 Interventional Completed Active Ulcerative Colitis
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00522457: Phase 2 Interventional Terminated Metastatic Breast Cancer
(2008)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04675333: Phase 2 Interventional Active, not recruiting Head and Neck Cancer
(2021)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:sampeginterferon beta-1a [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04189614: Phase 1 Interventional Active, not recruiting Cancer
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03736772: Phase 1 Interventional Completed Healthy
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02743546: Phase 1 Interventional Withdrawn Leukemia, Lymphocytic, Chronic, B-Cell
(2016)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04544111: Phase 2 Interventional Active, not recruiting Thyroid Cancer
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:timigutuzumab [INN]
Source URL:
Class:
PROTEIN
